Search filters

List of works by Claudio Festuccia

Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro.

scientific article published on July 2005

Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors

scientific article

Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo

scientific article published on 27 February 2020

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

scientific article published on 19 January 2009

Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels

scientific article published on 13 March 2009

Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer

scientific article published in September 2007

Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement

scientific article published on October 2002

Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells

scientific article

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

scientific article published on 01 September 2019

Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma

scientific article published on 09 January 2020

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

scientific article published on 29 January 2004

Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models

scientific article

Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling.

scientific article published in April 2018

Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.

scientific article published on 14 January 2005

Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro.

scientific article

Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.

scientific article published on 22 May 2008

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.

scientific article

Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment

scientific article

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

scientific article published on 24 November 2018

In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma

scientific article

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells

scientific article published on 18 December 2012

Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells

scientific article published on May 2004

Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators

scientific article

Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells

scientific article published on 14 September 2006

Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice

scientific article published on March 2006

Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer

scientific article published in October 2007

Targeted Molecular Therapy in Glioblastoma

scientific article published on 14 January 2020